AVS Life Sciences Acquires ValidPath

January 13, 2026

AVS Life Sciences acquired ValidPath, a biotech quality engineering leader focused on CQV (commissioning, qualification, and validation) services for life sciences manufacturers. The acquisition expands AVS’s end-to-end quality, regulatory, and engineering capabilities across pharmaceutical, biotech, medical device, and diagnostic industries.

Buyers
AVS Life Sciences
Targets
ValidPath
Sellers
ABI Group Inc. (represented the seller)
Location
California, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.